Google DeepMind has a weapon in the AI talent wars: aggressive noncompete rules
Some Google DeepMind staff are subject to noncompete agreements that stop them working for a rival for up to a year.
Google DeepMind’s AGI Plan: What Marketers Need to Know
Google DeepMind's AGI roadmap reveals how AI tools will evolve by 2030. Here's what it might mean for SEO, content creation, ...
DeepMind is holding back release of AI research to give Google an edge
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
Google DeepMind AI Accomplishes a Difficult Minecraft Task Without Knowing How to Play the Game
AI can now play the bestselling game Minecraft — and accomplish a multi-step task without being trained. A study published on ...
eWeek1d
From Slam Dunks to Salad-Making, Google’s Gemini Robots Are Coming for Everyday Life
Google DeepMind unveiled its new family of AI Gemini 2.0 models designed for multimodal robots. Google CEO Sundar Pichai said ...
The Next Web1d
DeepMind’s new research restrictions threaten AI innovation, warns Iris.ai CEO
Google DeepMind has reportedly restricted on sharing research will stifle AI innovation, warns the CEO of Iris.ai, one of ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Google replaces the leader of its consumer AI apps: report
Google reshuffles AI leadership with Sissie Hsiao stepping down and Josh Woodward stepping in to drive Gemini's evolution.
Google’s DeepMind Tightens AI Research Release amid AI Competition
AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Dataquest2d
Google DeepMind releases TxGemma: Open AI Models for Drug Discovery
In a move that could accelerate and reshape therapeutic development, Google DeepMind has launched TxGemma, a suite of open AI models designed to make drug discovery faster, smarter, and more ...